185 related articles for article (PubMed ID: 23839902)
1. n-3 polyunsaturated fatty acids and atrial fibrillation in patients with chronic heart failure: the GISSI-HF trial.
Aleksova A; Masson S; Maggioni AP; Lucci D; Fabbri G; Beretta L; Mos L; Paino AM; Nicolosi GL; Marchioli R; Tognoni G; Tavazzi L; Sinagra G; Latini R;
Eur J Heart Fail; 2013 Nov; 15(11):1289-95. PubMed ID: 23839902
[TBL] [Abstract][Full Text] [Related]
2. Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial.
Maggioni AP; Fabbri G; Lucci D; Marchioli R; Franzosi MG; Latini R; Nicolosi GL; Porcu M; Cosmi F; Stefanelli S; Tognoni G; Tavazzi L;
Eur Heart J; 2009 Oct; 30(19):2327-36. PubMed ID: 19717850
[TBL] [Abstract][Full Text] [Related]
3. Plasma n-3 polyunsaturated fatty acids in chronic heart failure in the GISSI-Heart Failure Trial: relation with fish intake, circulating biomarkers, and mortality.
Masson S; Marchioli R; Mozaffarian D; Bernasconi R; Milani V; Dragani L; Tacconi M; Marfisi RM; Borgese L; Cirrincione V; Febo O; Nicolis E; Maggioni AP; Tognoni G; Tavazzi L; Latini R
Am Heart J; 2013 Feb; 165(2):208-15.e4. PubMed ID: 23351824
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial.
Saravanan P; Bridgewater B; West AL; O'Neill SC; Calder PC; Davidson NC
Circ Arrhythm Electrophysiol; 2010 Feb; 3(1):46-53. PubMed ID: 20042769
[TBL] [Abstract][Full Text] [Related]
5. n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study.
Bianconi L; Calò L; Mennuni M; Santini L; Morosetti P; Azzolini P; Barbato G; Biscione F; Romano P; Santini M
Europace; 2011 Feb; 13(2):174-81. PubMed ID: 21059740
[TBL] [Abstract][Full Text] [Related]
6. Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial.
Mentz RJ; Chung MJ; Gheorghiade M; Pang PS; Kwasny MJ; Ambrosy AP; Vaduganathan M; O'Connor CM; Swedberg K; Zannad F; Konstam MA; Maggioni AP
Am Heart J; 2012 Dec; 164(6):884-92.e2. PubMed ID: 23194489
[TBL] [Abstract][Full Text] [Related]
7. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.
Tavazzi L; Maggioni AP; Marchioli R; Barlera S; Franzosi MG; Latini R; Lucci D; Nicolosi GL; Porcu M; Tognoni G;
Lancet; 2008 Oct; 372(9645):1223-30. PubMed ID: 18757090
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling.
Sakabe M; Shiroshita-Takeshita A; Maguy A; Dumesnil C; Nigam A; Leung TK; Nattel S
Circulation; 2007 Nov; 116(19):2101-9. PubMed ID: 17967774
[TBL] [Abstract][Full Text] [Related]
9. N-3 polyunsaturated fatty acids in heart failure: mechanisms and recent clinical evidence.
Marchioli R; Silletta MG; Levantesi G; Pioggiarella R; Tognoni G
Cell Mol Biol (Noisy-le-grand); 2010 Feb; 56(1):110-30. PubMed ID: 20196975
[TBL] [Abstract][Full Text] [Related]
10. Atrial protective effects of n-3 polyunsaturated fatty acids: a long-term study in ovine chronic heart failure.
Lau DH; Psaltis PJ; Carbone A; Kelly DJ; Mackenzie L; Worthington M; Metcalf RG; Kuklik P; Nelson AJ; Zhang Y; Wong CX; Brooks AG; Saint DA; James MJ; Edwards J; Young GD; Worthley SG; Sanders P
Heart Rhythm; 2011 Apr; 8(4):575-82. PubMed ID: 21145429
[TBL] [Abstract][Full Text] [Related]
11. Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial.
Mozaffarian D; Marchioli R; Macchia A; Silletta MG; Ferrazzi P; Gardner TJ; Latini R; Libby P; Lombardi F; O'Gara PT; Page RL; Tavazzi L; Tognoni G;
JAMA; 2012 Nov; 308(19):2001-11. PubMed ID: 23128104
[TBL] [Abstract][Full Text] [Related]
12. Reduced incidence of vagally induced atrial fibrillation and expression levels of connexins by n-3 polyunsaturated fatty acids in dogs.
Sarrazin JF; Comeau G; Daleau P; Kingma J; Plante I; Fournier D; Molin F
J Am Coll Cardiol; 2007 Oct; 50(15):1505-12. PubMed ID: 17919572
[TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
O'Meara E; Khairy P; Blanchet MC; de Denus S; Pedersen OD; Levesque S; Talajic M; Ducharme A; White M; Racine N; Rouleau JL; Tardif JC; Roy D;
Circ Heart Fail; 2012 Sep; 5(5):586-93. PubMed ID: 22798522
[TBL] [Abstract][Full Text] [Related]
14. Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial.
Marchioli R; Levantesi G; Silletta MG; Barlera S; Bernardinangeli M; Carbonieri E; Cosmi F; Franzosi MG; Latini R; Lucci D; Maggioni AP; Moretti L; Nicolosi GL; Porcu M; Rossi MG; Tognoni G; Tavazzi L;
Expert Rev Cardiovasc Ther; 2009 Jul; 7(7):735-48. PubMed ID: 19589110
[TBL] [Abstract][Full Text] [Related]
15. Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study.
Wu JH; Lemaitre RN; King IB; Song X; Sacks FM; Rimm EB; Heckbert SR; Siscovick DS; Mozaffarian D
Circulation; 2012 Mar; 125(9):1084-93. PubMed ID: 22282329
[TBL] [Abstract][Full Text] [Related]
16. Serum long-chain n-3 polyunsaturated fatty acids and risk of hospital diagnosis of atrial fibrillation in men.
Virtanen JK; Mursu J; Voutilainen S; Tuomainen TP
Circulation; 2009 Dec; 120(23):2315-21. PubMed ID: 19933935
[TBL] [Abstract][Full Text] [Related]
17. n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study.
Nodari S; Triggiani M; Campia U; Manerba A; Milesi G; Cesana BM; Gheorghiade M; Dei Cas L
Circulation; 2011 Sep; 124(10):1100-6. PubMed ID: 21844082
[TBL] [Abstract][Full Text] [Related]
18. The effects of omega-3 polyunsaturated fatty acids on cardiac rhythm: a critical reassessment.
Billman GE
Pharmacol Ther; 2013 Oct; 140(1):53-80. PubMed ID: 23735203
[TBL] [Abstract][Full Text] [Related]
19. A U-shaped association between consumption of marine n-3 fatty acids and development of atrial fibrillation/atrial flutter-a Danish cohort study.
Rix TA; Joensen AM; Riahi S; Lundbye-Christensen S; Tjønneland A; Schmidt EB; Overvad K
Europace; 2014 Nov; 16(11):1554-61. PubMed ID: 24574493
[TBL] [Abstract][Full Text] [Related]
20. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
Linssen GC; Rienstra M; Jaarsma T; Voors AA; van Gelder IC; Hillege HL; van Veldhuisen DJ
Eur J Heart Fail; 2011 Oct; 13(10):1111-20. PubMed ID: 21642293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
